UniProt ID | DNJC8_HUMAN | |
---|---|---|
UniProt AC | O75937 | |
Protein Name | DnaJ homolog subfamily C member 8 | |
Gene Name | DNAJC8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 253 | |
Subcellular Localization | Nucleus . | |
Protein Description | Suppresses polyglutamine (polyQ) aggregation of ATXN3 in neuronal cells. [PubMed: 27133716] | |
Protein Sequence | MAASGESGTSGGGGSTEEAFMTFYSEVKQIEKRDSVLTSKNQIERLTRPGSSYFNLNPFEVLQIDPEVTDEEIKKRFRQLSILVHPDKNQDDADRAQKAFEAVDKAYKLLLDQEQKKRALDVIQAGKEYVEHTVKERKKQLKKEGKPTIVEEDDPELFKQAVYKQTMKLFAELEIKRKEREAKEMHERKRQREEEIEAQEKAKREREWQKNFEESRDGRVDSWRNFQANTKGKKEKKNRTFLRPPKVKMEQRE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAASGESGT ------CCCCCCCCC | 15.44 | 19413330 | |
4 | Phosphorylation | ----MAASGESGTSG ----CCCCCCCCCCC | 33.29 | 23401153 | |
7 | Phosphorylation | -MAASGESGTSGGGG -CCCCCCCCCCCCCC | 51.39 | 24043423 | |
9 | Phosphorylation | AASGESGTSGGGGST CCCCCCCCCCCCCCH | 33.21 | 28348404 | |
10 | Phosphorylation | ASGESGTSGGGGSTE CCCCCCCCCCCCCHH | 38.68 | 28348404 | |
15 | Phosphorylation | GTSGGGGSTEEAFMT CCCCCCCCHHHHHHH | 35.60 | 25849741 | |
16 | Phosphorylation | TSGGGGSTEEAFMTF CCCCCCCHHHHHHHH | 40.91 | 28348404 | |
22 | Phosphorylation | STEEAFMTFYSEVKQ CHHHHHHHHHHHHHH | 16.99 | 24043423 | |
24 | Phosphorylation | EEAFMTFYSEVKQIE HHHHHHHHHHHHHHH | 8.51 | 24043423 | |
25 | Phosphorylation | EAFMTFYSEVKQIEK HHHHHHHHHHHHHHH | 31.55 | 24043423 | |
35 | Phosphorylation | KQIEKRDSVLTSKNQ HHHHHHHCCCCCHHH | 24.06 | 30266825 | |
38 | Phosphorylation | EKRDSVLTSKNQIER HHHHCCCCCHHHHHH | 35.18 | 23403867 | |
39 | Phosphorylation | KRDSVLTSKNQIERL HHHCCCCCHHHHHHH | 26.00 | 23403867 | |
40 | 2-Hydroxyisobutyrylation | RDSVLTSKNQIERLT HHCCCCCHHHHHHHC | 47.86 | - | |
40 | Ubiquitination | RDSVLTSKNQIERLT HHCCCCCHHHHHHHC | 47.86 | 32015554 | |
47 | Phosphorylation | KNQIERLTRPGSSYF HHHHHHHCCCCCCCC | 40.83 | 28450419 | |
51 | Phosphorylation | ERLTRPGSSYFNLNP HHHCCCCCCCCCCCH | 25.25 | 28450419 | |
52 | Phosphorylation | RLTRPGSSYFNLNPF HHCCCCCCCCCCCHH | 39.39 | 28450419 | |
53 | Phosphorylation | LTRPGSSYFNLNPFE HCCCCCCCCCCCHHC | 9.74 | 28122231 | |
74 | Ubiquitination | EVTDEEIKKRFRQLS CCCHHHHHHHHHHHH | 40.97 | 29967540 | |
75 | Acetylation | VTDEEIKKRFRQLSI CCHHHHHHHHHHHHH | 63.53 | 7265649 | |
81 | Phosphorylation | KKRFRQLSILVHPDK HHHHHHHHHHCCCCC | 12.92 | 29514088 | |
88 | Acetylation | SILVHPDKNQDDADR HHHCCCCCCCCHHHH | 62.04 | 25953088 | |
105 | Acetylation | KAFEAVDKAYKLLLD HHHHHHHHHHHHHCC | 47.20 | 25953088 | |
105 | Ubiquitination | KAFEAVDKAYKLLLD HHHHHHHHHHHHHCC | 47.20 | 22817900 | |
107 | Phosphorylation | FEAVDKAYKLLLDQE HHHHHHHHHHHCCHH | 14.12 | 28674151 | |
108 | Acetylation | EAVDKAYKLLLDQEQ HHHHHHHHHHCCHHH | 37.20 | 25953088 | |
108 | Ubiquitination | EAVDKAYKLLLDQEQ HHHHHHHHHHCCHHH | 37.20 | 22817900 | |
116 | 2-Hydroxyisobutyrylation | LLLDQEQKKRALDVI HHCCHHHHHHHHHHH | 43.40 | - | |
116 | Ubiquitination | LLLDQEQKKRALDVI HHCCHHHHHHHHHHH | 43.40 | 29967540 | |
117 | Ubiquitination | LLDQEQKKRALDVIQ HCCHHHHHHHHHHHH | 42.47 | 24816145 | |
118 | Methylation | LDQEQKKRALDVIQA CCHHHHHHHHHHHHH | 47.63 | - | |
118 | Dimethylation | LDQEQKKRALDVIQA CCHHHHHHHHHHHHH | 47.63 | - | |
127 | 2-Hydroxyisobutyrylation | LDVIQAGKEYVEHTV HHHHHHHHHHHHHHH | 49.22 | - | |
127 | Ubiquitination | LDVIQAGKEYVEHTV HHHHHHHHHHHHHHH | 49.22 | 33845483 | |
129 | Phosphorylation | VIQAGKEYVEHTVKE HHHHHHHHHHHHHHH | 18.02 | 28152594 | |
133 | Phosphorylation | GKEYVEHTVKERKKQ HHHHHHHHHHHHHHH | 21.55 | 28152594 | |
135 | Ubiquitination | EYVEHTVKERKKQLK HHHHHHHHHHHHHHH | 53.62 | 24816145 | |
135 | Acetylation | EYVEHTVKERKKQLK HHHHHHHHHHHHHHH | 53.62 | 23749302 | |
143 | Ubiquitination | ERKKQLKKEGKPTIV HHHHHHHHCCCCCCC | 79.06 | 29967540 | |
143 | Acetylation | ERKKQLKKEGKPTIV HHHHHHHHCCCCCCC | 79.06 | 26822725 | |
146 | Acetylation | KQLKKEGKPTIVEED HHHHHCCCCCCCCCC | 39.83 | 19608861 | |
146 | Ubiquitination | KQLKKEGKPTIVEED HHHHHCCCCCCCCCC | 39.83 | 19608861 | |
159 | Acetylation | EDDPELFKQAVYKQT CCCHHHHHHHHHHHH | 50.39 | 26051181 | |
159 | Ubiquitination | EDDPELFKQAVYKQT CCCHHHHHHHHHHHH | 50.39 | 29967540 | |
176 | 2-Hydroxyisobutyrylation | LFAELEIKRKEREAK HHHHHHHHHHHHHHH | 48.30 | - | |
176 | Ubiquitination | LFAELEIKRKEREAK HHHHHHHHHHHHHHH | 48.30 | 33845483 | |
201 | Ubiquitination | EEIEAQEKAKREREW HHHHHHHHHHHHHHH | 47.32 | 24816145 | |
210 | Ubiquitination | KREREWQKNFEESRD HHHHHHHHHHHHHCC | 65.75 | 29967540 | |
215 | Phosphorylation | WQKNFEESRDGRVDS HHHHHHHHCCCCCCC | 28.59 | 23403867 | |
222 | Phosphorylation | SRDGRVDSWRNFQAN HCCCCCCCHHHHHCC | 25.69 | 23401153 | |
224 | Methylation | DGRVDSWRNFQANTK CCCCCCHHHHHCCCC | 37.73 | - | |
230 | Phosphorylation | WRNFQANTKGKKEKK HHHHHCCCCCCCCCC | 44.16 | - | |
231 | Ubiquitination | RNFQANTKGKKEKKN HHHHCCCCCCCCCCC | 69.42 | 27667366 | |
237 | Ubiquitination | TKGKKEKKNRTFLRP CCCCCCCCCCCCCCC | 53.40 | 24816145 | |
239 | Methylation | GKKEKKNRTFLRPPK CCCCCCCCCCCCCCC | 35.42 | - | |
240 | Phosphorylation | KKEKKNRTFLRPPKV CCCCCCCCCCCCCCC | 36.09 | 28555341 | |
243 | Methylation | KKNRTFLRPPKVKME CCCCCCCCCCCCCHH | 41.08 | - | |
248 | Sumoylation | FLRPPKVKMEQRE-- CCCCCCCCHHHCC-- | 42.73 | - | |
248 | Sumoylation | FLRPPKVKMEQRE-- CCCCCCCCHHHCC-- | 42.73 | - | |
248 | Ubiquitination | FLRPPKVKMEQRE-- CCCCCCCCHHHCC-- | 42.73 | 24816145 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DNJC8_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DNJC8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNJC8_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A4_HUMAN | APP | physical | 21832049 | |
RAP1A_HUMAN | RAP1A | physical | 22939629 | |
PIN4_HUMAN | PIN4 | physical | 22939629 | |
TPX2_HUMAN | TPX2 | physical | 22939629 | |
HMGA1_HUMAN | HMGA1 | physical | 18850631 | |
HS74L_HUMAN | HSPA4L | physical | 26344197 | |
HYOU1_HUMAN | HYOU1 | physical | 26344197 | |
NEDD8_HUMAN | NEDD8 | physical | 26344197 | |
TRAP1_HUMAN | TRAP1 | physical | 27173435 | |
SND1_HUMAN | SND1 | physical | 27173435 | |
ANXA5_HUMAN | ANXA5 | physical | 27173435 | |
UBE2N_HUMAN | UBE2N | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-146, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-215, AND MASSSPECTROMETRY. |